Cargando…
Efficacy and safety of eplerenone treatment for patients with diabetic nephropathy: A meta-analysis
Diabetic nephropathy (DN), which is correlated with an increased risk of cardiovascular disease, significantly elevates the morbidity and mortality of patients with diabetes. Recently, the benefits of mineralocorticoid receptor antagonists in chronic kidney disease (CKD), such as their anti-inflamma...
Autores principales: | Hu, Honglei, Zhao, Xiaodong, Jin, Xingqian, Wang, Shujuan, Liang, Wenlong, Cong, Xiangguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947092/ https://www.ncbi.nlm.nih.gov/pubmed/35324976 http://dx.doi.org/10.1371/journal.pone.0265642 |
Ejemplares similares
-
Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis
por: Hu, Honglei, et al.
Publicado: (2023) -
Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats
por: Ahn, Jae Hee, et al.
Publicado: (2012) -
Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
por: Sadda, Srinivas R.
Publicado: (2020) -
Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015) -
Eplerenone ethanol solvate
por: Yang, Qian, et al.
Publicado: (2008)